DD202168A5 - Verfahren zur herstellung eines glycoproteins - Google Patents

Verfahren zur herstellung eines glycoproteins Download PDF

Info

Publication number: DD202168A5
Authority: DD; German Democratic Republic
Prior art keywords: substance; coriolus; solution; determined; item
Prior art date: 1981-02-10

Application number

DD82237287A

Other languages

German (de)

English (en)

Inventor

Chikao Yoshikumi

Takoyoshi Fujii

Takao Furusho

Kenichi Matsunaga

Minoru Ohara

Akira Kobayashi

Original Assignee

Kureha Chemical Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-02-10

Filing date

1982-02-09

Publication date

1983-08-31

1982-02-09 Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd

1983-08-31 Publication of DD202168A5 publication Critical patent/DD202168A5/de

Links

108090000288 Glycoproteins Proteins 0.000 title claims abstract description 18
102000003886 Glycoproteins Human genes 0.000 title claims abstract description 18
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 claims abstract description 54
150000001413 amino acids Chemical group 0.000 claims abstract description 32
239000000203 mixture Substances 0.000 claims abstract description 27
235000001014 amino acid Nutrition 0.000 claims abstract description 25
108020004707 nucleic acids Proteins 0.000 claims abstract description 16
102000039446 nucleic acids Human genes 0.000 claims abstract description 16
150000007523 nucleic acids Chemical class 0.000 claims abstract description 16
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims abstract description 9
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 9
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 9
235000004279 alanine Nutrition 0.000 claims abstract description 9
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims abstract description 8
OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 claims abstract description 8
229910052698 phosphorus Inorganic materials 0.000 claims abstract description 8
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims abstract description 8
239000004474 valine Substances 0.000 claims abstract description 7
239000010200 folin Substances 0.000 claims abstract description 6
229910052717 sulfur Inorganic materials 0.000 claims abstract description 6
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
238000002360 preparation method Methods 0.000 claims abstract description 5
238000005199 ultracentrifugation Methods 0.000 claims abstract description 4
229910052757 nitrogen Inorganic materials 0.000 claims abstract 2
239000000126 substance Substances 0.000 claims description 151
239000000243 solution Substances 0.000 claims description 36
150000001720 carbohydrates Chemical class 0.000 claims description 21
241000222355 Trametes versicolor Species 0.000 claims description 20
102000004169 proteins and genes Human genes 0.000 claims description 18
108090000623 proteins and genes Proteins 0.000 claims description 18
235000018102 proteins Nutrition 0.000 claims description 17
241000222356 Coriolus Species 0.000 claims description 12
241000233866 Fungi Species 0.000 claims description 11
238000001556 precipitation Methods 0.000 claims description 8
230000008569 process Effects 0.000 claims description 7
238000000108 ultra-filtration Methods 0.000 claims description 7
238000000502 dialysis Methods 0.000 claims description 6
239000000284 extract Substances 0.000 claims description 3
239000012670 alkaline solution Substances 0.000 claims description 2
241001676647 Trametes pubescens Species 0.000 claims 1
238000010586 diagram Methods 0.000 claims 1
108020001775 protein parts Proteins 0.000 abstract description 13
239000002246 antineoplastic agent Substances 0.000 abstract description 7
229910052799 carbon Inorganic materials 0.000 abstract description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract description 2
239000003814 drug Substances 0.000 abstract description 2
125000000837 carbohydrate group Chemical group 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 38
210000004698 lymphocyte Anatomy 0.000 description 33
238000006243 chemical reaction Methods 0.000 description 24
229940024606 amino acid Drugs 0.000 description 23
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
206010028980 Neoplasm Diseases 0.000 description 19
230000000694 effects Effects 0.000 description 18
230000000259 anti-tumor effect Effects 0.000 description 16
210000002540 macrophage Anatomy 0.000 description 15
241000699670 Mus sp. Species 0.000 description 13
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 13
208000006268 Sarcoma 180 Diseases 0.000 description 12
239000002244 precipitate Substances 0.000 description 12
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
241000699666 Mus <mouse, genus> Species 0.000 description 9
239000012981 Hank's balanced salt solution Substances 0.000 description 8
239000001963 growth medium Substances 0.000 description 8
238000012360 testing method Methods 0.000 description 8
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
239000002253 acid Substances 0.000 description 7
230000004520 agglutination Effects 0.000 description 7
201000011510 cancer Diseases 0.000 description 7
210000003743 erythrocyte Anatomy 0.000 description 7
238000002474 experimental method Methods 0.000 description 7
239000008103 glucose Substances 0.000 description 7
230000001506 immunosuppresive effect Effects 0.000 description 7
230000005764 inhibitory process Effects 0.000 description 7
239000000047 product Substances 0.000 description 7
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
108090001090 Lectins Proteins 0.000 description 6
102000004856 Lectins Human genes 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
230000037396 body weight Effects 0.000 description 6
239000002523 lectin Substances 0.000 description 6
230000000503 lectinlike effect Effects 0.000 description 6
150000002772 monosaccharides Chemical class 0.000 description 6
239000002504 physiological saline solution Substances 0.000 description 6
229940104230 thymidine Drugs 0.000 description 6
230000009466 transformation Effects 0.000 description 6
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
238000010521 absorption reaction Methods 0.000 description 5
239000008363 phosphate buffer Substances 0.000 description 5
235000011007 phosphoric acid Nutrition 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
230000000638 stimulation Effects 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
238000002054 transplantation Methods 0.000 description 5
229940035893 uracil Drugs 0.000 description 5
206010003445 Ascites Diseases 0.000 description 4
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 4
102000008857 Ferritin Human genes 0.000 description 4
108050000784 Ferritin Proteins 0.000 description 4
238000008416 Ferritin Methods 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
241000700159 Rattus Species 0.000 description 4
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
238000000862 absorption spectrum Methods 0.000 description 4
230000004913 activation Effects 0.000 description 4
230000007059 acute toxicity Effects 0.000 description 4
231100000403 acute toxicity Toxicity 0.000 description 4
239000000427 antigen Substances 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
230000001766 physiological effect Effects 0.000 description 4
229920001282 polysaccharide Polymers 0.000 description 4
239000005017 polysaccharide Substances 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
235000000346 sugar Nutrition 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
238000011740 C57BL/6 mouse Methods 0.000 description 3
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
210000000683 abdominal cavity Anatomy 0.000 description 3
239000003513 alkali Substances 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
239000002585 base Substances 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
238000012790 confirmation Methods 0.000 description 3
238000001816 cooling Methods 0.000 description 3
238000011033 desalting Methods 0.000 description 3
238000001035 drying Methods 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000004811 liquid chromatography Methods 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
-1 nitrogen-containing polysaccharide Chemical class 0.000 description 3
QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 3
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
235000008729 phenylalanine Nutrition 0.000 description 3
239000011574 phosphorus Substances 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000005406 washing Methods 0.000 description 3
LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 description 2
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
244000105624 Arachis hypogaea Species 0.000 description 2
235000010777 Arachis hypogaea Nutrition 0.000 description 2
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
102000005367 Carboxypeptidases Human genes 0.000 description 2
108010006303 Carboxypeptidases Proteins 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 2
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
241000222357 Trametes hirsuta Species 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
239000013543 active substance Substances 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000012530 fluid Substances 0.000 description 2
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
229930182830 galactose Natural products 0.000 description 2
238000004817 gas chromatography Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
229960002442 glucosamine Drugs 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000003301 hydrolyzing effect Effects 0.000 description 2
HHIVCXLCMPHUSC-UHFFFAOYSA-N hydron;1h-indol-1-ium;sulfate Chemical compound OS(O)(=O)=O.C1=CC=C2NC=CC2=C1 HHIVCXLCMPHUSC-UHFFFAOYSA-N 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
230000028993 immune response Effects 0.000 description 2
238000011534 incubation Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
229940067606 lecithin Drugs 0.000 description 2
239000000787 lecithin Substances 0.000 description 2
235000010445 lecithin Nutrition 0.000 description 2
239000000463 material Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
230000000284 resting effect Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
235000004400 serine Nutrition 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000010414 supernatant solution Substances 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
235000008521 threonine Nutrition 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000000954 titration curve Methods 0.000 description 2
238000012546 transfer Methods 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
KAZDQJDOHTVZDQ-VDQHJUMDSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2,5-diaminopentanoic acid Chemical compound NCCC[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O KAZDQJDOHTVZDQ-VDQHJUMDSA-N 0.000 description 1
LCTORNIWLGOBPB-GASJEMHNSA-N (3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound NC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LCTORNIWLGOBPB-GASJEMHNSA-N 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
BMGWZHWESYHXHC-UHFFFAOYSA-N 2-amino-3-methylpentanoic acid;2-amino-4-methylpentanoic acid Chemical compound CCC(C)C(N)C(O)=O.CC(C)CC(N)C(O)=O BMGWZHWESYHXHC-UHFFFAOYSA-N 0.000 description 1
GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
ZRKHIAJIHKHTDY-UHFFFAOYSA-N 5-methylbenzene-1,3-diol;hydrochloride Chemical compound Cl.CC1=CC(O)=CC(O)=C1 ZRKHIAJIHKHTDY-UHFFFAOYSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
101000588924 Anthopleura elegantissima Delta-actitoxin-Ael1a Proteins 0.000 description 1
235000017060 Arachis glabrata Nutrition 0.000 description 1
235000018262 Arachis monticola Nutrition 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241000974482 Aricia saepiolus Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
229930182476 C-glycoside Natural products 0.000 description 1
150000000700 C-glycosides Chemical class 0.000 description 1
244000045232 Canavalia ensiformis Species 0.000 description 1
235000010520 Canavalia ensiformis Nutrition 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
206010060891 General symptom Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
238000004566 IR spectroscopy Methods 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
108010047620 Phytohemagglutinins Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000004847 absorption spectroscopy Methods 0.000 description 1
238000005273 aeration Methods 0.000 description 1
GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
PNNNRSAQSRJVSB-KCDKBNATSA-N aldehydo-L-fucose Chemical compound C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-KCDKBNATSA-N 0.000 description 1
PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
230000002924 anti-infective effect Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
229940041181 antineoplastic drug Drugs 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
238000004380 ashing Methods 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
238000010533 azeotropic distillation Methods 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
230000032823 cell division Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012136 culture method Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000004522 effect on agglutination Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
230000005484 gravity Effects 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000036039 immunity Effects 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
235000014705 isoleucine Nutrition 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
150000002540 isothiocyanates Chemical class 0.000 description 1
239000010977 jade Substances 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
150000008146 mannosides Chemical class 0.000 description 1
239000002609 medium Substances 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229950006780 n-acetylglucosamine Drugs 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 1
235000020232 peanut Nutrition 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
239000000575 pesticide Substances 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
230000001885 phytohemagglutinin Effects 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
150000003214 pyranose derivatives Chemical group 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000011218 seed culture Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229910000033 sodium borohydride Inorganic materials 0.000 description 1
239000012279 sodium borohydride Substances 0.000 description 1
ULJWXUZHULWYTB-UHFFFAOYSA-M sodium;acetonitrile;dihydrogen phosphate Chemical compound [Na+].CC#N.OP(O)([O-])=O ULJWXUZHULWYTB-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000009967 tasteless effect Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
238000004448 titration Methods 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
150000003680 valines Chemical class 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

DD82237287A 1981-02-10 1982-02-09 Verfahren zur herstellung eines glycoproteins DD202168A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP56018655A JPS5932480B2 (ja)	1981-02-10	1981-02-10	新規な糖蛋白複合体

Publications (1)

Publication Number	Publication Date
DD202168A5 true DD202168A5 (de)	1983-08-31

Family

ID=11977627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD82237287A DD202168A5 (de)	1981-02-10	1982-02-09	Verfahren zur herstellung eines glycoproteins

Country Status (11)

Country	Link
US (1)	US4663438A (fr)
EP (1)	EP0058093B1 (fr)
JP (1)	JPS5932480B2 (fr)
AU (1)	AU551672B2 (fr)
CA (1)	CA1184899A (fr)
DD (1)	DD202168A5 (fr)
DE (1)	DE3261014D1 (fr)
PH (2)	PH18378A (fr)
RO (1)	RO82759B (fr)
SU (1)	SU1291027A3 (fr)
ZA (1)	ZA82511B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3448145C2 (fr)	1983-08-11	1989-09-21	Kureha Kagaku Kogyo K.K., Tokio/Tokyo, Jp
NL8401225A (nl) *	1984-04-16	1985-11-18	Univ Utrecht	Farmaceutisch produkt met anti-tumor werking; gebruik van een farmaceutisch produkt of van farmaceutische samenstellingen in een antitumor therapie.
JPS61130235A (ja) *	1984-11-28	1986-06-18	Sunstar Inc	感染症治療薬
US4828821A (en) *	1986-08-22	1989-05-09	Collaborative Research, Inc.	Method of inhibiting calculus formulation and improving dental hygiene
EP0295956B1 (fr) *	1987-06-18	1996-09-11	Kureha Kagaku Kogyo Kabushiki Kaisha	Utilisation d'un polysaccharide lié a une protéine pour préparer un médicament destiné au traitement du SIDA.
JPH0825896B2 (ja) *	1987-06-18	1996-03-13	呉羽化学工業株式会社	抗レトロウィルス剤
JPS6466127A (en) *	1987-09-07	1989-03-13	Nichirei Kk	Antitumor agent
JPH0816119B2 (ja) *	1987-09-24	1996-02-21	呉羽化学工業株式会社	蛋白多糖体ｋｖ−０７１及びそれを有効成分とするヒトロタウイルス感染症予防剤
JPH0816118B2 (ja) *	1988-02-03	1996-02-21	呉羽化学工業株式会社	抗ウイルス剤
JPH08208704A (ja) *	1995-02-06	1996-08-13	Kureha Chem Ind Co Ltd	新規な糖タンパク質複合体、その製造方法、並びに抗腫瘍剤、免疫調節剤及び増殖因子阻害剤
RU2223781C2 (ru) *	2000-07-13	2004-02-20	Закрытое Акционерное Общество Производственное Предприятие "Эндо-Фарм-А"	Новый класс физиологически активных гликопротеинов
US7048932B2 (en) *	2002-05-22	2006-05-23	The Chinese University Of Hong Kong	Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
RU2007145748A (ru) *	2007-12-11	2009-06-20	ОАО Завод экологической техники и экопитания "ДИОД" (RU)	Штамм гриба hypsizygus ulmarius (bull.) redhead s-ulm1, используемый для получения средства, обладающего противоопухолевой активностью и антиоксидантным действием и способ получения средства, обладающего противоопухолевой активностью и антиоксидантным действием, на основе этого штамма
CN116879481B (zh) *	2023-09-06	2023-12-01	北京豪思生物科技股份有限公司	一种血清中芳香族氨基酸的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE757248A (fr) *	1969-10-15	1971-04-08	Kureha Chemical Ind Co Ltd	Substance a propriete anticancereuse et procedes pour sa preparation
JPS5290614A (en) *	1975-12-18	1977-07-30	Kureha Chem Ind Co Ltd	Preparation of anti-tumor substance
PH14773A (en) *	1976-01-01	1981-12-09	Kureha Chemical Ind Co Ltd	Protein-bound polysaccharides
JPS536413A (en) *	1976-07-07	1978-01-20	Kureha Chem Ind Co Ltd	Preparation of n-containing polysaccharides
JPS536412A (en) *	1976-07-07	1978-01-20	Kureha Chem Ind Co Ltd	Preparation of n-containing polysaccharides
JPS5315495A (en) *	1976-07-22	1978-02-13	Kureha Chem Ind Co Ltd	Preparation of polysaccharides
JPS5446830A (en) *	1977-09-16	1979-04-13	Kureha Chem Ind Co Ltd	Pesticide for plant viral disease

1981
- 1981-02-10 JP JP56018655A patent/JPS5932480B2/ja not_active Expired
1982
- 1982-01-26 ZA ZA82511A patent/ZA82511B/xx unknown
- 1982-01-29 CA CA000395240A patent/CA1184899A/fr not_active Expired
- 1982-02-02 PH PH26815A patent/PH18378A/en unknown
- 1982-02-03 AU AU80166/82A patent/AU551672B2/en not_active Ceased
- 1982-02-09 DD DD82237287A patent/DD202168A5/de not_active IP Right Cessation
- 1982-02-09 SU SU823396893A patent/SU1291027A3/ru active
- 1982-02-09 RO RO106582A patent/RO82759B/ro unknown
- 1982-02-10 DE DE8282300661T patent/DE3261014D1/de not_active Expired
- 1982-02-10 EP EP82300661A patent/EP0058093B1/fr not_active Expired
1983
- 1983-10-04 PH PH29659A patent/PH18757A/en unknown
1985
- 1985-03-25 US US06/715,816 patent/US4663438A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ZA82511B (en)	1982-12-29
US4663438A (en)	1987-05-05
EP0058093B1 (fr)	1984-10-24
EP0058093A1 (fr)	1982-08-18
PH18757A (en)	1985-09-19
JPS5932480B2 (ja)	1984-08-09
AU551672B2 (en)	1986-05-08
RO82759B (ro)	1984-01-30
PH18378A (en)	1985-06-19
CA1184899A (fr)	1985-04-02
RO82759A (fr)	1984-01-14
DE3261014D1 (en)	1984-11-29
AU8016682A (en)	1982-08-19
JPS57134496A (en)	1982-08-19
SU1291027A3 (ru)	1987-02-15

Legal Events

Date	Code	Title	Description
1999-05-12	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DD202168A5 (de)	1983-08-31	Verfahren zur herstellung eines glycoproteins
DE2331144A1 (de)	1974-01-10	Wasserloesliche extrakte von mycobacterien
DE2659808C3 (de)	1980-04-03	Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE2638762A1 (de)	1977-03-10	Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0225496A2 (fr)	1987-06-16	Polysaccharides immunostimulantes à partir de cultures de cellules d'Echinacea purpurea (Linné) Moench et d'Echinacea angustifolia (De Vandolle), leur procédé de préparation et compositions pharmaceutiques les contenant
EP0212595B1 (fr)	1992-08-05	Complexes de calcium et magnésium de phytohémaglutinine-polyhétéroglycanes, leur obtention et préparations pharmaceutiques
DE2441454A1 (de)	1975-03-27	Verfahren zur herstellung eines heilmittels fuer leukaemie
DE3109335A1 (de)	1982-03-18	Die neue, physiologisch wirksame substanz ebelacton und verfahren zur herstellung derselben
DE69315388T2 (de)	1998-05-14	Aus bakteriellen Proteinen bestehender Extrakt, Verfahren zur dessen Herstellung und diesen Extrakt enthaltende pharmazeutische Zusammensetzung
DE69731891T2 (de)	2005-12-01	Verfahren zur reinigung von gbs-toxin/cm101
DE3881198T2 (de)	1993-09-02	Antiviraler wirkstoff.
EP0220453B1 (fr)	1992-04-15	Application d'extraits de pollen de plantes à la préparation de compositions pharmaceutiques ralentissant la croissance de cellules tumorales et procédé pour leur préparation
DE2701890C2 (de)	1983-08-04	Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2723451C2 (fr)	1989-09-07
CH640868A5 (de)	1984-01-31	3-0-(beta-d-glucoronpyranosyl)-sojasapogenol b, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE3787971T2 (de)	1994-04-07	Aktives prinzip, isoliert aus haigeweben.
EP0395851B1 (fr)	1996-06-26	Glycoprotéines d'Avena sativa procédé pour les obtenir et leur utilisation comme médicaments
CH657989A5 (de)	1986-10-15	Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
DE19600301C2 (de)	1999-12-09	Durch Cyclooligomerisierung des einfachen Kohlensuboxids C¶3¶O¶2¶ aufgebaute makrocyclische Verbindungen, Verfahren zu deren Herstellung und Gewinnung sowie deren Verwendung
EP0991773B1 (fr)	2003-08-13	Complexe glucidique extrait de mycobacterium tuberculosis et son procede de preparation
DE69724156T2 (de)	2004-05-27	Aus mycobacterium tuberculosis extrahierter kohlenwasserstoffkomplex und verfahren zu dessen herstellung
DE2408724A1 (de)	1974-09-05	Biologische extrakte und verfahren zu ihrer herstellung
DE2803681C2 (fr)	1989-03-16
EP0173950A2 (fr)	1986-03-12	Inhibiteur d'alpha-glucosidase, méthode pour le préparer, son application et ses compositions pharmaceutiques
DE2146674C3 (de)	1981-10-29	Faktor und seine Verwendung als Arzneimittel